Medicines A–Z
T
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Tacrolimus 0.03% ointment (30g) | ||
|
Tacrolimus 0.1% ointment (30g) | ||
 |
Tacrolimus 0.1% w/w in OrabaseTM | Unlicensed special |
|
|
Tacrolimus 0.3% w/w in OrabaseTM | Unlicensed special |
|
|
Tacrolimus capsules (Prograf) | New post-transplant |
|
|
Tacrolimus capsules (Prograf) | Post-transplant pre 2015 |
|
|
Tacrolimus prolonged release capsules (Advagraf) | New post-transplant |
|
|
Tacrolimus prolonged release capsules (Advagraf) | Post-transplant pre 2015 |
|
|
Tacrolimus | Specialist use only in neurological conditions |
|
 |
Tadalafil 10mg | High relative cost. In line with SLS criteria. Four tab per month - on demand. Non-formulary for LUTS in BPS. |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
